Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Central Line”

1,370 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,370 results

Post-approval studies (Phase 4)Study completedNCT00555282
What this trial is testing

Rate of Catheter Colonization and Risk of Bloodstream Infection During Use of Two Different Central Venous Catheters (CVC)

Who this might be right for
BacteriaemiaCatheter Related Bloodstream Infection
B. Braun Melsungen AG 680
Large-scale testing (Phase 3)Looking for participantsNCT06767527
What this trial is testing

AK112 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/ Metastatic Triple-negative Breast Cancer

Who this might be right for
Triple-Negative Breast Cancer (TNBC)
Akeso 416
Large-scale testing (Phase 3)Study completedNCT04449861
What this trial is testing

Durvalumab Plus Chemotherapy in ES-SCLC (Oriental)

Who this might be right for
Small Cell Lung Carcinoma Extensive Disease
AstraZeneca 166
Not applicableUnknownNCT04462861
What this trial is testing

A New Securement Method for External Tunneled Central Venous Access Devices (CVAD)

Who this might be right for
Central Venous Catheter Exit Site InfectionCentral Venous Catheter Related Bloodstream Infection
University of Colorado, Denver 20
Testing effectiveness (Phase 2)Study completedNCT04271813
What this trial is testing

Anlotinib Plus Sintilimab as First-line Treatment for Patients With Advanced Colorectal Cancer (APICAL-CRC)

Who this might be right for
Colorectal CancerImmunotherapyAnlotinib+3 more
Shanghai Changzheng Hospital 30
Not applicableStudy completedNCT01970397
What this trial is testing

JUVEDERM® Ultra XC vs. Belotero Balance® for Perioral Lines

Who this might be right for
Patients With Moderate to Severe Perioral Lines
Allergan 138
Testing effectiveness (Phase 2)UnknownNCT05342389
What this trial is testing

Camrelizumab Combined With Apatinib Versus Apatinib Alone in the Third-line Treatment of Metastatic Gastric Cancer

Who this might be right for
Metastatic Gastric AdenocarcinomaMetastatic Gastroesophageal Junction Adenocarcinoma
Sixth Affiliated Hospital, Sun Yat-sen University 68
Not applicableLooking for participantsNCT07024680
What this trial is testing

Real World Study of Effectiveness of Sunitinib or Sorafenib to Chinese Unresectable Locally Advanced or Metastatic PRCC

Who this might be right for
Papillary Renal Cell Carcinoma
AstraZeneca 150
Testing effectiveness (Phase 2)Study completedNCT00430586
What this trial is testing

Finding of Optimal Dose for NT 201 in the Treatment of Glabellar Frown Lines

Who this might be right for
Glabellar Frown Lines
Merz Pharmaceuticals GmbH 191
Testing effectiveness (Phase 2)Study completedNCT00828841
What this trial is testing

Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Accelerated Community Oncology Research Network 601
Early research (Phase 1)Study completedNCT04944953
What this trial is testing

To Compare the Safety and Efficacy of "HG-102" With Botox® in the Improvement of Moderate to Severe Glabellar Lines.

Who this might be right for
Glabellar Lines
Hugel 38
Not applicableUnknownNCT04692753
What this trial is testing

Effect of Education of Health Care Workers on the Maintenance of Venous Access Devices

Who this might be right for
Vascular Access Devices
Post Graduate Institute of Medical Education and Research, Chandigarh 400
Not applicableLooking for participantsNCT07143045
What this trial is testing

A Prospective Cohort Study of Zorifertinib as a First-line Treatment in Patients With Epidermal Growth Factor Receptor-mutant Advanced Non-small Cell Lung Cancer With Central Nervous System (CNS) Metastases

Who this might be right for
EGFR Mutant Advanced Non-small Cell Lung CancerCentral Nervous System (CNS) Metastases
Alpha Biopharma (Jiangsu) Co., Ltd. 800
Large-scale testing (Phase 3)Looking for participantsNCT05382728
What this trial is testing

Phase III Study of TY-9591 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer (FLETEO)

Who this might be right for
NSCLCEGFR Activating Mutation
TYK Medicines, Inc 680
Large-scale testing (Phase 3)Active Not RecruitingNCT06583486
What this trial is testing

A Study on the Efficacy and Safety of Repeated Treatments With Recombinant Botulinum Toxin Type A for Injection in the Treatment of Moderate to Severe Glabellar Lines

Who this might be right for
Moderate to Severe Glabellar Lines
Chongqing Claruvis Pharmaceutical Co., Ltd. 488
Large-scale testing (Phase 3)Study completedNCT01878422
What this trial is testing

Sequential Treatment Strategy for Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 376
Not applicableLooking for participantsNCT07291869
What this trial is testing

Central Venous Catheter Placement With Thoracic Ultrasound and Intracavity ECG Positioning

Who this might be right for
Central Venous CatheterPoint of Care Ultrasound (POCUS)Intracavitary Electrocardiogram Guiding+1 more
York Teaching Hospitals NHS Foundation Trust 75
Post-approval studies (Phase 4)WithdrawnNCT00510627
What this trial is testing

Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases

Who this might be right for
Metastatic Liver CancerSecondary Liver CancerLiver Neoplasm
Boston Scientific Corporation
Large-scale testing (Phase 3)Study completedNCT02551159
What this trial is testing

Phase III Open Label Study of MEDI 4736 With/Without Tremelimumab Versus Standard of Care (SOC) in Recurrent/Metastatic Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
AstraZeneca 823
Not applicableLooking for participantsNCT07106970
What this trial is testing

PVI Alone vs PVI and Linear Ablation for Persistent Atrial Fibrillation (PROMPT AF II)

Who this might be right for
Persistent Atrial Fibrillation
Boston Scientific Corporation 640
Load More Results